Harvard Bioscience Inc (HBIO)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Harvey Partners

Jeffrey Moskowitz

2,557,500 $13,682,625 1.55%
2. 1,450,829 $7,761,935 +3% 0.07%
3. 819,750 $4,385,663 +2% 2.08%
4. 672,170 $3,596,110 +50% 0.31%
5.
Archon Capital Management

Constantinos J. Christofilis

279,358 $1,494,565 0.36%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.38 25,000 Officer, Director 2,862,679 2023-08-17 Filing
$2.62 16,192 Director 202,485 2023-03-15 Filing
$2.67 13,808 Director 186,293 2023-03-14 Filing
$2.60 20,000 Officer, Director 2,886,052 2023-03-15 Filing
$2.67 20,000 Officer, Director 2,866,052 2023-03-14 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.02 48,175 Officer, Director 2,091,725 2021-08-23 Filing
$7.14 24,312 Officer, Director 2,279,778 2021-05-21 Filing
$7.03 14,876 Officer, Director 2,279,778 2021-05-20 Filing
$7.17 39,188 Officer, Director 2,279,778 2021-05-19 Filing
$7.41 39,188 Officer, Director 2,279,788 2021-05-18 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 2,918,034 $15,611,482 0.91%
2. 2,913,814 $15,588,905 0%
3. 2,162,893 $11,571,478 10.39%
4. 2,102,571 $11,248,755 0%
5. 1,925,635 $10,302,329 0%
News See All